Active substance
Triamcinolone diacetate
- US FDA 8
- Safety 2
US FDA United States — FDA approvals (Drugs@FDA)
| Product | Strength | Form · route | Applicant | Status | First approved |
|---|---|---|---|---|---|
| ARISTOCORT | 25MG/ML | injectable · injection | FOSUN PHARMA | Discontinued | 12 Mar 1959 |
| ARISTOCORT | 2MG/5ML | syrup · oral | ASTELLAS | Discontinued | 2 Sep 1959 |
| KENACORT | EQ 4MG BASE/5ML | syrup · oral | DELCOR ASSET CORP | Discontinued | 21 Mar 1961 |
| ARISTOCORT | 40MG/ML **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | injectable · injection | FOSUN PHARMA | Discontinued | 5 Sep 1961 |
| TRIAMCINOLONE DIACETATE | 40MG/ML | injectable · injection | WATSON LABS | Discontinued | 24 Jan 1977 |
| TRIAMCINOLONE DIACETATE | 25MG/ML | injectable · injection | EPIC PHARMA LLC | Discontinued | |
| TRIAMCINOLONE DIACETATE | 40MG/ML | injectable · injection | WATSON LABS | Discontinued | |
| TRIAMCINOLONE DIACETATE | 40MG/ML | injectable · injection | EPIC PHARMA LLC | Discontinued |
Safety signals and safety-related labeling changes
- US FDA 5 Jun 2024 ARISTOCORT — safety-related labeling change
Labeling sections changed: Warnings and Precautions - US FDA 5 Jun 2024 ARISTOCORT — safety-related labeling change
Labeling sections changed: Warnings and Precautions
Values as published by each source: SFDA human drug list (4-2026, as published by the Council of Health Insurance; indications from the CHI Daman Drug Formulary), Drugs@FDA, EMA medicines data, Health Canada Drug Product Database (Open Government Licence – Canada), CMS NADAC, NHS Drug Tariff Part VIIIA (NHSBSA Copyright, Open Government Licence v3.0), WHO Model List of Essential Medicines (CC BY 3.0 IGO; regrouped by active substance, not created by WHO), EMA PRAC, US FDA safety-related labeling changes and MHRA Drug Safety Update (Open Government Licence v3.0). Sources and reuse. Not a substitute for the official registers or the product information.